Skip to main content

Published locations for Ponatinib’s toxicity limits use for upfront chronic phase CML

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ponatinib’s toxicity limits use for upfront chronic phase CML

User login

  • Reset your password
  • /content/ponatinibs-toxicity-limits-use-upfront-chronic-phase-cml
  • /hematologynews/article/103374/lymphoma-plasma-cell-disorders/ponatinibs-toxicity-limits-use-upfront
  • /oncologypractice/article/103374/lymphoma-plasma-cell-disorders/ponatinibs-toxicity-limits-use
  • /hematology-oncology/article/103374/lymphoma-plasma-cell-disorders/ponatinibs-toxicity-limits-use